




Instance: composition-en-7257da0dd1f9dbf780b362b25cce238a
InstanceOf: CompositionUvEpi
Title: "Composition for cuprior Package Leaflet"
Description:  "Composition for cuprior Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "EU/1/17/1199/001 72 film-coated tablets"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mp7257da0dd1f9dbf780b362b25cce238a)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - cuprior"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #en
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What is in this leaflet</p>
<ol>
<li>What Cuprior is and what it is used for  </li>
<li>What you need to know before you take Cuprior  </li>
<li>How to take Cuprior  </li>
<li>Possible side effects  </li>
<li>How to store Cuprior  </li>
<li>Contents of the pack and other information </li>
</ol>         </div>"""   
          

* section[=].section[+]
  * title =  "1. What cuprior is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What cuprior is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Cuprior is a medicine used to treat Wilson s disease that contains the active substance trientine.  </p>
<p>Wilson s disease is an inherited condition in which the body cannot transport copper around the body 
in the normal way or remove copper in the normal way as a secretion from the liver into the gut. This 
means that the small amounts of copper from food and drink build up to excessive levels and can lead 
to liver damage and problems in the nervous system. This medicine mainly works by attaching to 
copper in the body which then allows it to be removed in the urine instead, helping to lower copper 
levels. It may also attach to copper in the gut and so reduce the amount taken up into the body.<br />
Cuprior is given to adults, adolescents and children aged 5 years and over who cannot tolerate another 
medicine that is used to treat this disease, called penicillamine. </p>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take cuprior"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take cuprior"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Do not take Cuprior 
- if you are allergic to trientine or any of the other ingredients of this medicine (listed in 
section 6).  </p>
<p>Warnings and precautions<br />
Talk to your doctor or pharmacist before taking Cuprior. </p>
<p>If you were already taking another trientine medicine, your doctor may modify your daily dose, the 
number of tablets or the number of intake in the day when switching to Cuprior treatment.  </p>
<p>Your symptoms may initially get worse after starting the treatment. If this happens, you must tell your 
doctor. </p>
<p>Your doctor will regularly check your blood and urine to ensure that you receive the right dose of 
Cuprior to properly control your symptoms and copper levels.  </p>
<p>You should tell your doctor if you get any side effects as this may indicate that your dose of Cuprior 
needs to be adjusted up or down.  </p>
<p>This medicine may also reduce the level of iron in your blood and your doctor may prescribe iron 
supplements (see section  Other medicines and Cuprior  below). </p>
<p>If you have kidney problems, your doctor will regularly check that the treatment dose is appropriate 
and does not affect the functioning of your kidney. </p>
<p>The association of trientine with another medicine that contains zinc is not recommended.  </p>
<p>Lupus-like reactions (symptoms may include persistent rash, fever, joint pain, and tiredness) have 
been reported in some patients switched to trientine medicine after penicillamine medicine. However it 
was not possible to determine if the reaction was due to trientine or to previous penicillamine 
treatment.  </p>
<p>Children and adolescents 
Your doctor will carry out checks more frequently to ensure your copper levels are maintained at a 
suitable level for normal growth and mental development.<br />
This medicine is not recommended for children aged below 5 years of age. </p>
<p>Other medicines and Cuprior 
Tell your doctor if you are taking, have recently taken, or might take any other medicines.  </p>
<p>In particular, you must tell your doctor if you are already taking iron supplements or if you take 
indigestion remedies (medicines that reduce discomfort after eating). If you take these medicines you 
may need to take Cuprior at a different time in the day because otherwise Cuprior may not be as 
effective. If you take iron supplements, make sure that at least two hours have passed between taking 
Cuprior and taking your iron supplements. </p>
<p>Pregnancy and breast-feeding<br />
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask 
your doctor for advice before taking this medicine.  </p>
<p>It is very important to continue treatment to reduce copper during pregnancy. You and your doctor 
should fully discuss the potential benefits of treatment whilst considering any possible risks that there 
may be. Your doctor will advise you which treatment and which dose is best in your situation. </p>
<p>If you are pregnant and taking Cuprior, you will be monitored throughout your pregnancy for any 
effects on the baby or changes in your copper levels. When your baby is born, the copper level in the 
baby s blood will also be monitored.  </p>
<p>It is not known if Cuprior can pass into breast milk. It is important to tell your doctor if you are 
breast-feeding or plan to do so. Your doctor will then help you decide whether to stop breast-feeding 
or to stop taking Cuprior, considering the benefit of breast-feeding to the baby and the benefit of 
Cuprior to the mother. Your doctor will decide which treatment and which dose is best in your 
situation. </p>
<p>Driving and using machines 
Cuprior is not expected to affect your ability to drive a car or use any tools or machines. </p>
<p>Cuprior contains sodium 
This medicine contains less than 1 mmol sodium (23 mg) per dose, that is to say essentially  sodium-
free.  </p>         </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take cuprior"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take cuprior"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor 
or pharmacist if you are not sure.  </p>
<p>Adults<br />
In adults of all ages, the recommended total daily dose is 3 to 6 and a half tablets per day (making a 
total of between 450 and 975 mg). This daily total will be divided into 2 to 4 smaller doses to be taken 
during the day. Your doctor will tell you how many tablets you should take and how often in the day. 
Tablets can be divided in half if needed. </p>
<p>Use in children and adolescents (5 to 18 years) 
The dose that you will take is usually lower than for an adult and depends on your age and body 
weight.<br />
The usual total daily dose is between 225 and 600 mg (1 and a half to 4 tablets daily), which will be 
divided into 2 to 4 smaller doses to be taken during the day. Your doctor will tell you how many 
tablets you should take and how often in the day. Tablets can be divided in half if needed. </p>
<p>Once you have started the treatment, your doctor may adjust the dose based on the response to 
treatment. </p>
<p>Swallow the tablets with water. Take this medicine on an empty stomach, at least one hour before 
meals or two hours after meals and at least one hour apart from any other medicines, food, or milk. </p>
<p>If you take iron supplements, take them at least two hours after taking a dose of Cuprior. </p>
<p>If you take more Cuprior than you should 
Take Cuprior only as it is prescribed for you. If you think you may have taken more Cuprior than you 
were told to, contact your doctor or pharmacist. 
If you take more than you should, you may get nausea, vomiting and dizziness. </p>
<p>If you forget to take Cuprior 
Do not take a double dose to make up for a forgotten dose. Skip the missed dose and  take your next 
dose at its usual scheduled time. </p>
<p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist. </p>
<p>If you stop taking Cuprior 
This medicine is for long-term use. Do not stop your treatment without the advice of your doctor even 
if you feel better because Wilson s disease is a life-long condition. </p>
<p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist. </p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Like all medicines, this medicine can cause side effects, although not everybody gets them. </p>
<p>The following side effects have been reported: </p>
<p>Common (may affect up to 1 in 10 people) 
- feeling sick (nausea)  </p>
<p>Uncommon (may affect up to 1 in 100 people) 
- skin rashes 
- reddening of the skin (erythema) 
- itching 
- anaemia </p>
<p>Not known (frequency cannot be estimated from available data) 
- stomach upsets and discomfort, including severe stomach pains (duodenitis) <br />
- inflammation of the gut which may lead to e.g. abdominal pain, recurring diarrhoea and blood in 
stools (colitis) 
- decrease in the number of red blood cells due to low iron level in your blood (iron deficiency)<br />
- urticaria (nettle rash or hives). </p>
<p>Reporting of side effects 
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects 
not listed in this leaflet. You can also report side effects directly via the national reporting system 
listed in Appendix V. By reporting side effects you can help provide more information on the safety of 
this medicine. </p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store cuprior"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store cuprior"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Keep this medicine out of the sight and reach of children. </p>
<p>Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The 
expiry date refers to the last day of that month. </p>
<p>This medicine does not require any special storage conditions. </p>
<p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to 
throw away medicines you no longer use. These measures will help protect the environment. </p>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What Cuprior contains<br />
- The active substance is trientine. Each film-coated tablet  contains trientine tetrahydrochloride 
equivalent to 150 mg trientine.<br />
- The other ingredients are: 
Tablet core: mannitol, colloidal anhydrous silica and glycerol dibehenate. 
Tablet film-coating: polyvinyl alcohol, talc, titanium dioxide (E 171), glycerol monocaprylocaprate 
(Type I), iron oxide yellow (E 172) and sodium laurilsulfate (see section 2  Cuprior contains 
sodium ). </p>
<p>What Cuprior looks like and contents of the pack 
Cupior are yellow, 16 mm x 8 mm oblong film-coated tablets with a score line on each side.<br />
Cuprior is available in blisters containing 72 or 96 film-coated tablets. 
Not all pack sizes may be marketed. </p>
<p>Marketing Authorisation Holder<br />
Orphalan 
226 Boulevard Voltaire 
75011 Paris 
France </p>
<p>Manufacturer 
Delpharm Evreux 
5 rue du Guesclin 
27000 Evreux 
France </p>
<p>This leaflet was last revised in. </p>
<p>You can find the information also when flashing the QR code below with a smartphone or via the 
website QR code to be included http://www.cuprior.com </p>
<p>Other sources of information </p>
<p>Detailed information on this medicine is available on the European Medicines Agency web site: </p>         </div>"""      



Instance: composition-da-7257da0dd1f9dbf780b362b25cce238a
InstanceOf: CompositionUvEpi
Title: "Composition for cuprior Package Leaflet"
Description:  "Composition for cuprior Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "EU/1/17/1199/001 72 film-coated tablets"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mp7257da0dd1f9dbf780b362b25cce238a)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - cuprior"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #da
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Oversigt over indlægssedlen </p>
<ol>
<li>Virkning og anvendelse  </li>
<li>Det skal du vide, før du begynder at tage Cuprior  </li>
<li>Sådan skal du tage Cuprior  </li>
<li>Bivirkninger  </li>
<li>Opbevaring  </li>
<li>Pakningsstørrelser og yderligere oplysninger </li>
</ol>         </div>"""   
          

* section[=].section[+]
  * title =  "1. What cuprior is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What cuprior is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Cuprior er et lægemiddel til behandling af Wilsons sygdom og indeholder det aktive stof trientin.  </p>
<p>Wilsons sygdom er en arvelig sygdom, hvor kroppen ikke kan transportere kobber rundt i organismen 
på normal måde eller fjerne kobber på normal måde ved at udskille det fra leveren til tarmen. Det 
medfører, at små mængder kobber fra mad og drikke ophobes i for store mængder og kan forårsage 
leverskade og problemer i nervesystemet. Dette lægemiddel virker hovedsagelig ved at bindes til 
kroppens indhold af kobber, der derved i stedet kan udskilles gennem urinen, så indholdet af kobber 
mindskes. Det kan desuden bindes til kobber i tarmen og derved mindske den mængde, der optages i 
kroppen.<br />
Cuprior gives til voksne og børn over 5 år, som ikke tåler et andet lægemiddel (penicillamin), der 
anvendes til behandling af sygdommen. </p>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take cuprior"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take cuprior"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Tag ikke Cuprior 
- hvis du er allergisk over for trientin eller et af de øvrige indholdsstoffer i Cuprior (angivet i 
afsnit 6).  </p>
<p>Advarsler og forsigtighedsregler<br />
Kontakt lægen eller apotekspersonalet, før du tager Cuprior. </p>
<p>Hvis du i forvejen er i behandling med et andet lægemiddel med trientin, vil din læge måske ændre din 
daglige dosis, antallet af tabletter eller det antal gange, du dagligt indtager dem, når du skifter til 
behandling med Cuprior.  </p>
<p>Dine symptomer kan i begyndelsen blive værre efter påbegyndelse af behandlingen. Hvis det sker, 
skal du kontakte til lægen. </p>
<p>Lægen vil regelmæssigt kontrollere dit blod og din urin for at sikre, at du får en passende dosis af 
Cuprior til at kontrollere dine symptomer og din kobberkoncentration.  </p>
<p>Du skal kontakte lægen, hvis du får bivirkninger, da det kan være tegn på, at din dosis af Cuprior 
behøver justeres op eller ned.  </p>
<p>Dette lægemiddel kan desuden nedsætte indholdet af jern i blodet, og lægen vil måske ordinere 
jerntilskud (se afsnittet "Brug af anden medicin sammen med Cuprior" nedenfor). </p>
<p>Hvis du har nyreproblemer, vil lægen regelmæssigt kontrollere, at behandlingsdosis er passende og 
ikke påvirker din nyrefunktion. </p>
<p>Det frarådes at kombinere trientin med et andet lægemiddel, der indeholder zink.  </p>
<p>Der er beskrevet lupuslignende reaktioner (med symptomer, der kan bestå i vedholdende udslæt, feber, 
ledsmerter og træthed) hos nogle patienter, som har skiftet til lægemidler indeholdende trientin efter at 
have fået penicillamin. Det har imidlertid ikke kunnet fastslås, om reaktionen skyldtes trientin eller 
den forudgående penicillamin-behandling.  </p>
<p>Børn og unge 
Lægen vil oftere foretage undersøgelser for at sikre, at din koncentration af kobber holdes på et 
passende niveau med henblik på normal vækst og mental udvikling.<br />
Det frarådes at anvende lægemidlet til børn under 5 år. </p>
<p>Brug af anden medicin sammen med Cuprior 
Fortæl lægen, hvis du bruger anden medicin, har gjort det for nylig eller påtænker at gøre det.  </p>
<p>Navnlig skal du fortælle lægen, om du allerede får jerntilskud eller får lægemidler mod 
fordøjelsesbesvær (lægemidler, der mindsker ubehaget efter måltider). Hvis du får sådanne 
lægemidler, er du måske nødt til at tage Cuprior på et andet tidspunkt af dagen, da Cuprior måske 
ellers ikke er så effektivt. Hvis du får jerntilskud, skal der gå mindst to timer efter at du har taget 
Cuprior, før du tager jerntilskud. </p>
<p>Graviditet og amning<br />
Hvis du er gravid eller ammer, har mistanke om, at du er gravid, eller planlægger at blive gravid, skal 
du spørge din læge til råds, før du bruger dette lægemiddel.  </p>
<p>Det er meget vigtigt at fortsætte behandlingen for at nedsætte kobberkoncentrationen under 
graviditeten. Du og din læge skal gennemdrøfte de mulige fordele ved behandlingen og tage alle 
mulige risici i betragtning. Lægen vil rådgive dig om, hvilken behandling og hvilken dosis der er bedst 
i din situation. </p>
<p>Hvis du er gravid og får Cuprior, vil du blive overvåget gennem hele graviditeten med hensyn til 
eventuel påvirkning af barnet og ændringer i din kobberværdi. Når du har født dit barn, vil 
kobberindholdet i barnets blod ligeledes blive overvåget.  </p>
<p>Det vides ikke, om Cuprior kan gå over i modermælken. Det er vigtigt at fortælle lægen, om du ammer 
eller har til hensigt at gøre det. Lægen vil så hjælpe dig med at afgøre, om du skal holde op med at 
amme eller holde op med at tage Cuprior, ud fra fordelen ved amning for barnet og fordelen ved 
Cuprior for dig. Lægen vil afgøre, hvilken behandling og hvilken dosis der er bedst i din situation. </p>
<p>Trafik- og arbejdssikkerhed 
Cuprior forventes ikke at påvirke din evne til at føre motorkøretøj eller betjene maskiner. </p>
<p>Cuprior indeholder natrium 
Dette lægemiddel indeholder mindre end 1 mmol (23 mg) natrium pr. dosis, dvs. det er i det 
væsentlige natriumfrit. </p>         </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take cuprior"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take cuprior"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Tag altid dette lægemiddel nøjagtigt efter lægens eller apotekspersonalets anvisning. Er du i tvivl, så 
spørg lægen eller på apoteket.  </p>
<p>Voksne 
Hos voksne i alle aldre er den anbefalede totale dagsdosis 3 til 6 og en halv tabletter (svarende til i alt 
mellem 450 og 975 mg). Den totale dagsdosis fordeles på 2-4 mindre doser, der tages i løbet af dagen. 
Lægen vil fortælle dig, hvor mange tabletter du skal tage og hvor ofte i løbet af dagen. Tabletten kan 
om nødvendigt deles i to halvdele. </p>
<p>Brug til børn og unge (5 til 18 år) 
Den dosis, du skal have, er sædvanligvis lavere end til en voksen og afhænger af din alder og din 
legemsvægt.<br />
Den normale totale dagsdosis er mellem 225 og 600 mg (1 og en halv til 4 tabletter dagligt), som 
fordeles på 2-4 mindre doser, der tages i løbet af dagen. Lægen vil fortælle dig, hvor mange tabletter 
du skal tage og hvor ofte i løbet af dagen. Tabletterne kan deles, hvis det er nødvendigt. </p>
<p>Efter at du er begyndt på behandlingen, vil lægen måske tilpasse dosis afhængigt af reaktionen på 
behandlingen. </p>
<p>Synk tabletterne med vand. Tag lægemidlet på tom mave mindst én time før et måltid eller to timer 
efter et måltid og mindst én time før eller efter ethvert andet lægemiddel, føde eller mælk. </p>
<p>Hvis du tager jerntilskud, skal du tage det mindst to timer efter at have taget en dosis af Cuprior. </p>
<p>Hvis du har taget for meget Cuprior 
Tag kun Cuprior, som det er ordineret til dig Hvis du mener at have taget for meget Cuprior i forhold 
til, hvad du har fået besked på, skal du kontakte lægen eller apoteket. 
Hvis du har taget for meget, kan du få kvalme, kaste op og blive svimmel. </p>
<p>Hvis du har glemt at tage Cuprior 
Du må ikke tage en dobbeltdosis som erstatning for den glemte dosis. Spring den glemte dosis over og 
tag blot næste dosis til den sædvanlige tid. </p>
<p>Tal med lægen eller apotekspersonalet, hvis der er mere, du vil vide om brugen af lægemidlet. </p>
<p>Hvis du holder op med at tage Cuprior 
Dette lægemiddel er til langtidsbehandling. Stop ikke behandlingen, medmindre lægen har sagt, at du 
skal gøre det, også selv om du føler dig bedre, da Wilsons sygdom er en livsvarig sygdom. </p>
<p>Tal med lægen eller apotekspersonalet, hvis der er mere, du vil vide om brugen af lægemidlet. </p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Dette lægemiddel kan som alle andre lægemidler give bivirkninger, men ikke alle får bivirkninger. </p>
<p>Der er indberettet følgende bivirkninger: </p>
<p>Almindelige (forekommer hos op til 1 ud af 10 personer):</p>
<ul>
<li>Kvalme  </li>
</ul>
<p>Ikke almindelige (forekommer hos op til 1 ud af 100 personer):</p>
<ul>
<li>Hududslæt </li>
<li>Rødme af huden (erytem) </li>
<li>Kløe </li>
<li>anæmi </li>
</ul>
<p>Ikke kendt (hyppigheden kan ikke beregnes ud fra forhåndenværende data):</p>
<ul>
<li>Mavebesvær og -ubehag, herunder svære mavesmerter (duodenitis)  </li>
<li>Inflammation af tarmen, som kan medføre fx mavesmerter, tilbagevendende diarré og blodig 
afføring (colitis) </li>
<li>Nedsat antal røde blodlegemer pga. lavt jernindhold i blodet (jernmangel)  </li>
<li>Nældefeber (urticaria) </li>
</ul>
<p>Indberetning af bivirkninger 
Hvis du oplever bivirkninger, bør du tale med din læge eller apoteket, herunder bivirkninger, som ikke 
er nævnt her. Du kan desuden indberette bivirkninger direkte gennem det nationale 
indberetningssystem, der er anført i Appendiks V. Ved at indberette bivirkninger kan du hjælpe med at 
fremskaffe mere information om sikkerheden af dette lægemiddel. </p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store cuprior"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store cuprior"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Opbevar lægemidlet utilgængeligt for børn. </p>
<p>Brug ikke lægemidlet efter den udløbsdato, der står på pakningen efter EXP. Udløbsdatoen er den 
sidste dag i den nævnte måned. </p>
<p>Dette lægemiddel kræver ingen særlige forholdsregler vedrørende opbevaringen. </p>
<p>Af hensyn til miljøet må du ikke smide medicinrester i afløbet eller skraldespanden. Spørg på 
apoteket, hvordan du skal bortskaffe medicinrester. Dette vil medvirke til at skåne miljøet. </p>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Cuprior indeholder:</p>
<ul>
<li>Aktivt stof: trientin. Hver filmovertrukket tablet indeholder trientintetrahydrochlorid svarende 
til 150 mg trientin.  </li>
<li>Øvrige indholdsstoffer:<br />
Tabletkerne indhold: mannitol, silica, kolloid, vandfri og glyceroldibehenat.. 
Tablettens filmovertræk: polyvinylalkohol, talcum, titandioxid (E 171), glycerolmonocaprylocaprat 
(Type I), gul jernoxid (E 172) og natriumlaurilsulfat (se afsnit 2 "Cuprior indeholder natrium"). </li>
</ul>
<p>Udseende og pakningsstørrelser 
Cuprior er gule aflange filmovertrukne tabletter, 16 mm x 8 mm, med delekærv på hver side. </p>
<p>Cuprior fås i blisters med 72 eller 96 filmovertrukne tabletter. 
Ikke alle pakningsstørrelser er nødvendigvis markedsført. </p>
<p>Indehaver af markedsføringstilladelsen<br />
Orphalan 
226 Boulevard Voltaire 
75011 Paris 
Frankrig </p>
<p>Fremstiller 
Delpharm Evreux 
5 rue du Guesclin 
27000 Evreux 
Frankrig </p>
<p>Denne indlægsseddel blev senest ændret  </p>
<p>Du kan også finde oplysningerne ved at aflæse nedenstående QR-kode med en smartphone, eller 
gennem webstedet QR code to be included http://www.cuprior.com </p>
<p>Andre informationskilder </p>
<p>Du kan finde yderligere oplysninger om dette lægemiddel på Det Europæiske Lægemiddelagenturs 
hjemmeside http://www.ema.europa.eu. Der er også links til andre websteder om sjældne sygdomme 
og om, hvordan de behandles.  </p>         </div>"""      





                    
Instance: bundlepackageleaflet-en-7257da0dd1f9dbf780b362b25cce238a
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for cuprior Package Leaflet for language en"
Description: "ePI document Bundle for cuprior Package Leaflet for language en"
Usage: #example


* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #en

// Composition
* entry[0].fullUrl = "Composition/composition-en-7257da0dd1f9dbf780b362b25cce238a"
* entry[0].resource = composition-en-7257da0dd1f9dbf780b362b25cce238a

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mp7257da0dd1f9dbf780b362b25cce238a"
* entry[=].resource = mp7257da0dd1f9dbf780b362b25cce238a
                            
                    
Instance: bundlepackageleaflet-da-7257da0dd1f9dbf780b362b25cce238a
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for cuprior Package Leaflet for language da"
Description: "ePI document Bundle for cuprior Package Leaflet for language da"
Usage: #example


* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #da

// Composition
* entry[0].fullUrl = "Composition/composition-da-7257da0dd1f9dbf780b362b25cce238a"
* entry[0].resource = composition-da-7257da0dd1f9dbf780b362b25cce238a

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mp7257da0dd1f9dbf780b362b25cce238a"
* entry[=].resource = mp7257da0dd1f9dbf780b362b25cce238a
                            
                    



Instance: mp7257da0dd1f9dbf780b362b25cce238a
InstanceOf: MedicinalProductDefinitionUvEpi
Title: "Medicinal Product Cuprior 150 mg film-coated tablets"
Description: "Cuprior 150 mg film-coated tablets"
Usage: #inline

 
* identifier[+].system = "http://ema.europa.eu/identifier"
* identifier[=].value = "EU/1/17/1199/001 72 film-coated tablets"
* type = http://hl7.org/fhir/medicinal-product-type#MedicinalProduct "Medicinal Product"

* domain = http://hl7.org/fhir/medicinal-product-domain#Human "Human use"

* status = http://hl7.org/fhir/publication-status#active "active"



* legalStatusOfSupply = $spor-rms#100000072084 "Medicinal product subject to medical prescription"

* name
  * productName = "Cuprior 150 mg film-coated tablets"
  * type = $spor-productNamePartType-cs#220000000001 "Full name" 
  
  * part[0]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000002 "Invented name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000003 "Scientific name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000004 "Strength part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000005 "Pharmaceutical dose form part"
  
  * usage
    * country = urn:iso:std:iso:3166#EU "EU"
    * jurisdiction = urn:iso:std:iso:3166#EU "EU"
    * language = urn:ietf:bcp:47#en  "en"



RuleSet: 7257da0dd1f9dbf780b362b25cce238aListRuleset

* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* identifier[+].system = "http://spor.ema.europa.eu/v2/medicine-name"
* identifier[=].value = "cuprior"

* status = #current
* mode = #working

* title = "List of all ePIs associated with cuprior"

* subject = Reference(mp7257da0dd1f9dbf780b362b25cce238a)
* subject.extension[0].url = "http://ema.europa.eu/fhir/extension/medicine-name"
* subject.extension[=].valueCoding = $100000000005#cuprior "cuprior"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/marketing-authorization-holder"
* subject.extension[=].valueCoding = $100000000005#mah-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/active-substance"
* subject.extension[=].valueCoding = $100000000005#acive-substance-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/domain"
* subject.extension[=].valueCoding = $100000000004#100000000012 "H"

* date = "2015-02-07T13:28:17Z"


* entry
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-en-7257da0dd1f9dbf780b362b25cce238a) // cuprior en
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "en"



* entry
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-da-7257da0dd1f9dbf780b362b25cce238a) // cuprior da
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "da"




Instance: List-7257da0dd1f9dbf780b362b25cce238a
InstanceOf: List

* insert 7257da0dd1f9dbf780b362b25cce238aListRuleset
    